MedTrace Logo

Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients

NCT00926224 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2010-11-16

No results posted yet for this study

Summary

The main objective of the study is to evaluate the diagnostic performance of the XL probe for estimating degree of liver fibrosis/cirrhosis in obese patients \> 28 kg/m² with various liver diseases in patients with chronic liver disease scheduled for a liver biopsy.

Conditions

  • Liver Fibrosis
  • Cirrhosis

Interventions

DEVICE

FibroScan M and XL probes

Each patient undergo two liver stiffness measurements with the FibroScan: once with the M probe and once with the XL probe

Sponsors & Collaborators

  • Echosens

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-07-31
Completion
2010-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00926224 on ClinicalTrials.gov